Literature DB >> 22820257

Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies.

Yi Du1, Alison Walsh, Robin Ehrick, Wei Xu, Kimberly May, Hongcheng Liu.   

Abstract

The existence of multiple variants with differences in either charge, molecular weight or other properties is a common feature of monoclonal antibodies. These charge variants are generally referred to as acidic or basic compared with the main species. The chemical nature of the main species is usually well-understood, but understanding the chemical nature of acidic and basic species, and the differences between all three species, is critical for process development and formulation design. Complete understanding of acidic and basic species, however, is challenging because both species are known to contain multiple modifications, and it is likely that more modifications may be discovered. This review focuses on the current understanding of the modifications that can result in the generation of acidic and basic species and their affect on antibody structure, stability and biological functions. Chromatography elution profiles and several critical aspects regarding fraction collection and sample preparations necessary for detailed characterization are also discussed.

Mesh:

Substances:

Year:  2012        PMID: 22820257      PMCID: PMC3499298          DOI: 10.4161/mabs.21328

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  69 in total

1.  Analysis of recombinant monoclonal antibody isoforms by electrospray ionization mass spectrometry as a strategy for streamlining characterization of recombinant monoclonal antibody charge heterogeneity.

Authors:  Yelena Lyubarskaya; Damian Houde; James Woodard; David Murphy; Rohin Mhatre
Journal:  Anal Biochem       Date:  2005-10-25       Impact factor: 3.365

2.  Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells.

Authors:  Alain Beck; Marie-Claire Bussat; Nathalie Zorn; Virginie Robillard; Christine Klinguer-Hamour; Stéphane Chenu; Liliane Goetsch; Nathalie Corvaïa; Alain Van Dorsselaer; Jean-François Haeuw
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-05-25       Impact factor: 3.205

3.  Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies.

Authors:  Dirk Chelius; Douglas S Rehder; Pavel V Bondarenko
Journal:  Anal Chem       Date:  2005-09-15       Impact factor: 6.986

4.  Structural characterization of a recombinant monoclonal antibody by electrospray time-of-flight mass spectrometry.

Authors:  Lintao Wang; Godfrey Amphlett; John M Lambert; Walter Blättler; Wei Zhang
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

5.  Heterogeneity of recombinant antibodies: linking structure to function.

Authors:  R J Harris
Journal:  Dev Biol (Basel)       Date:  2005

6.  Protein variant separations by cation-exchange chromatography on tentacle-type polymeric stationary phases.

Authors:  M Weitzhandler; D Farnan; J Horvath; J S Rohrer; R W Slingsby; N Avdalovic; C Pohl
Journal:  J Chromatogr A       Date:  1998-12-18       Impact factor: 4.759

7.  In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.

Authors:  Lihua Huang; Jirong Lu; Victor J Wroblewski; John M Beals; Ralph M Riggin
Journal:  Anal Chem       Date:  2005-03-01       Impact factor: 6.986

8.  Influence of pH, buffer species, and storage temperature on physicochemical stability of a humanized monoclonal antibody LA298.

Authors:  Jack Y Zheng; Linda J Janis
Journal:  Int J Pharm       Date:  2005-11-28       Impact factor: 5.875

9.  Validation of an HPLC method for the analysis of the charge heterogeneity of the recombinant monoclonal antibody IDEC-C2B8 after papain digestion.

Authors:  K G Moorhouse; W Nashabeh; J Deveney; N S Bjork; M G Mulkerrin; T Ryskamp
Journal:  J Pharm Biomed Anal       Date:  1997-12       Impact factor: 3.935

10.  Pharmacokinetics and organ distribution of cationized colchicine-specific IgG and Fab fragments in rat.

Authors:  G Hong; M I Bazin-Redureau; J M Scherrmann
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

View more
  45 in total

1.  Rapid quantitative analysis of monoclonal antibody heavy and light chain charge heterogeneity.

Authors:  Ram P Vanam; Michael A Schneider; Michael S Marlow
Journal:  MAbs       Date:  2015-08-25       Impact factor: 5.857

2.  Understanding the pathway and kinetics of aspartic acid isomerization in peptide mapping methods for monoclonal antibodies.

Authors:  June Kuang; Yuanqi Tao; Yuanli Song; Letha Chemmalil; Nesredin Mussa; Julia Ding; Zheng Jian Li
Journal:  Anal Bioanal Chem       Date:  2021-02-05       Impact factor: 4.142

3.  Platform Methods to Characterize the Charge Heterogeneity of Three Common Protein Therapeutics by Imaged Capillary Isoelectric Focusing.

Authors:  Jiaqi Wu; Will McElroy; Charles Haitjema; Carsten Lück; Christopher Heger
Journal:  Methods Mol Biol       Date:  2021

4.  Simple Western: Bringing the Western Blot into the Twenty-First Century.

Authors:  Carsten Lück; Charles Haitjema; Christopher Heger
Journal:  Methods Mol Biol       Date:  2021

5.  Antibody characterization using novel ERLIC-MS/MS-based peptide mapping.

Authors:  Jing Zhen; John Kim; Ying Zhou; Ervinas Gaidamauskas; Shyamsundar Subramanian; Ping Feng
Journal:  MAbs       Date:  2018-09-11       Impact factor: 5.857

6.  A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization.

Authors:  Yan An; Ying Zhang; Hans-Martin Mueller; Mohammed Shameem; Xiaoyu Chen
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

7.  Cysteinylation of a monoclonal antibody leads to its inactivation.

Authors:  Troy McSherry; Jennifer McSherry; Panfilo Ozaeta; Kenton Longenecker; Carol Ramsay; Jeffrey Fishpaugh; Steven Allen
Journal:  MAbs       Date:  2016-04-06       Impact factor: 5.857

8.  Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study.

Authors:  Neh Nupur; Nidhi Chhabra; Rozaleen Dash; Anurag S Rathore
Journal:  MAbs       Date:  2017-12-07       Impact factor: 5.857

9.  Modulating cell culture oxidative stress reduces protein glycation and acidic charge variant formation.

Authors:  Stanley Chung; Jun Tian; Zhijun Tan; Jie Chen; Na Zhang; Yunping Huang; Erik Vandermark; Jongchan Lee; Michael Borys; Zheng Jian Li
Journal:  MAbs       Date:  2019-01-03       Impact factor: 5.857

10.  Comparative analytical profiling of bevacizumab biosimilars marketed in India: a national control laboratory study.

Authors:  Anu Prakash; Nripendra N Mishra; Utpreksha Vaish; Sonia Sharma; Apoorva Anand; Richi V Mahajan; J P Prasad; Subhash Chand
Journal:  3 Biotech       Date:  2020-11-09       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.